Operating Expenses
Other nonrecurring (income) expense
Amgen Other nonrecurring (income) expense decreased by 113.6% to -$113.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2025
Last reportedQ1 2026Apr 30, 2026
How to read this metric
High volatility or recurring non-recurring items may signal underlying operational instability or frequent restructuring.
Detailed definition
This metric captures one-time or non-operational financial impacts that are not part of the company's core recurring bus...
Peer comparison
Varies significantly by company; often excluded by analysts when calculating adjusted earnings.
Metric ID:
lin_other_nonrecurring_income_expenseHistorical Data
2 periods
| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $830.00M | -$113.00M |
| QoQ Change | — | -113.6% |
| YoY Change | — | -113.6% |
Range-$113.00M – $830.00M
Avg YoY Growth-113.6%
Median YoY Growth-113.6%
Other nonrecurring (income) expense at Other Companies
Frequently Asked Questions
- What is Amgen's other nonrecurring (income) expense?
- Amgen (AMGN) reported other nonrecurring (income) expense of -$113.00M in Q1 2026.
- What does other nonrecurring (income) expense mean?
- Unusual or one-time gains or losses that are not expected to repeat in the future.